Vericel Corp. (VCEL)

15.71
0.26 1.70
NASDAQ : Health Technology
Prev Close 15.45
Open 15.28
Day Low/High 15.26 / 15.70
52 Wk Low/High 10.51 / 21.00
Volume 104.32K
Avg Volume 474.60K
Exchange NASDAQ
Shares Outstanding 44.14M
Market Cap 684.12M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Strong On High Volume: Vericel (VCEL)

Strong On High Volume: Vericel (VCEL)

Trade-Ideas LLC identified Vericel (VCEL) as a strong on high relative volume candidate

Vericel (VCEL) Is Weak On High Volume Today

Vericel (VCEL) Is Weak On High Volume Today

Trade-Ideas LLC identified Vericel (VCEL) as a weak on high relative volume candidate

Results From Vericel's Positive Phase 2b IxCELL-DCM Clinical Trial Of Ixmyelocel-T Presented Today At ACC And Published In The Lancet

Results From Vericel's Positive Phase 2b IxCELL-DCM Clinical Trial Of Ixmyelocel-T Presented Today At ACC And Published In The Lancet

Patients Treated with Ixmyelocel-T had a 37 Percent Reduction in Clinical Events Compared to Placebo

Vericel To Host Review Of Positive Phase 2b IxCELL-DCM Trial Results Following American College Of Cardiology 65th Annual Scientific Sessions

Vericel To Host Review Of Positive Phase 2b IxCELL-DCM Trial Results Following American College Of Cardiology 65th Annual Scientific Sessions

Key Opinion Leader to present full data results on April 5th in New York

Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Vericel (VCEL) as a "perilous reversal" (up big yesterday but down big today) candidate

Interesting VCEL Put And Call Options For May 20th

Interesting VCEL Put And Call Options For May 20th

Investors in Vericel Corp saw new options become available this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VCEL options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

Vericel (VCEL) Flagged As Strong On High Volume

Vericel (VCEL) Flagged As Strong On High Volume

Trade-Ideas LLC identified Vericel (VCEL) as a strong on high relative volume candidate

Vericel (VCEL) Flagged As Strong On High Volume

Vericel (VCEL) Flagged As Strong On High Volume

Trade-Ideas LLC identified Vericel (VCEL) as a strong on high relative volume candidate

Vericel (VCEL) Stock Falling on Q4 Results

Vericel (VCEL) Stock Falling on Q4 Results

Vericel (VCEL) stock is dipping on Monday morning after the biopharmaceutical company posted lower-than-expected results for the 2015 fourth quarter before today’s opening bell.

Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Vericel (VCEL) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Vericel (VCEL) as a "perilous reversal" (up big yesterday but down big today) candidate

Vericel (VCEL) Is Today's Pre-Market Mover With Heavy Volume Stock

Vericel (VCEL) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Vericel (VCEL) as a pre-market mover with heavy volume candidate

Vericel (VCEL) Stock Soars on Positive Phase 2 Trial Results

Vericel (VCEL) Stock Soars on Positive Phase 2 Trial Results

Vericel (VCEL) stock is surging in mid-morning trading Thursday after the company reported positive results from its Phase 2 trial for patients with heart failure due to ischemic dilated cardiomyopathy.

Vericel Announces FDA Approval Of Epicel HDE Supplement

Vericel Announces FDA Approval Of Epicel HDE Supplement

Revised Product Label Includes Indication for Use in Pediatric Patients and Now Specifies a Probable Benefit of Epicel Mainly Related to Patient Survival

TheStreet Quant Rating: D (Sell)